News for hackers. Stuff that matters.
Re:Transcriptic for YC biotech startups by dnautics on Monday December 08, 2014 @05:30PM (#8719665)
I have exactly the opposite opinion. Even scientists are captiviated by scientism - the idea that there is something poisonous about human subjectivity and imprecision and that removing subjectivity (and gathering more data) is necessarily a good. Sydney Brenner, for example has a 'money quote' about the path that biologists take: "low input, high throughput, no output science". Note that this quote doesn't make sense in an environment that doesn't faddishly flock to high througput 'big data' solutions.

Your example is greatly flawed. The biggest consumers of highly parallelizeable workflows is the pharmaceutical industry. Highly parallel medchem was a big fad and the number of drugs that it produced for its efforts is disappointing. The fact that 11% of Amgen's results are irreproducible is if anything a condemnation of parallel scaleup, at least in the context of an operator with a strong motive for selective interpretation.

Another big problem is that when you bring your numbers up, you 'get what you are looking for'. Precision optimization can optimize for an artefact. I joke I like to make is that sloppy science is good, because if you keep seeing the same result under a noisy platform, what you're seeing is probably real and, more encouragingly, robust.

There are no comments on this comment yet.